📰 Abuse Potential News
Abuse Potential News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abuse Potential. Real-time updates on events, politics, business and more.
November 22, 2023
Serenity, a natural supplement for the relief of symptoms of anxiety based on the clinically studied extract of lavender oil...
November 22, 2023
Serenity, a natural supplement for the relief of symptoms of anxiety based on the clinically studied extract of lavender oil TORONTO, Nov. 22, 2023 -- Lifeist Wellness Inc. , a health-tech...
August 2, 2023
Scitegrity Limited utilizes its expertise, extensive database of controlled substances, and industry-leading tools to quantitatively evaluate whether the candidate exhibits chemical similarity to known drugs of abuse.
July 3, 2023
On June 23, 2023 the U.S. Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs...
June 9, 2023
This article delves into the wide-ranging benefits, diverse applications, trial results, and avenues to buy Modafinil without a prescription.
May 31, 2023
Is addiction attributed to “the animal or the human within us” or is substance abuse unique to humans? This question has intrigued me...
May 24, 2023
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
October 31, 2022
~ Announces Timing of Corporate Update Call ~SAN DIEGO, CA / ACCESSWIRE / October 31, 2022 / Ensysce Biosciences Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech
October 14, 2022
This article focuses on FDA and EMA regulatory guidelines surrounding drug abuse/dependence and abuse potential investigations, particularly in...
August 23, 2022
Completion of Clinical Portion Represents Critical Milestone Towards CommercializationNasal Opioid Abuse Being Explored for PF614Data From Trial Expected in September 2022SAN DIEGO, CA / ACCESSWIRE / August